Efficacy and safety of Corbrin Capsule on malnutrition, inflammation, and atherosclerosis syndrome in patients with uremia: systematic review and meta-analysis | Zendy

Zhang-Ru Rui | Zendy; Yiru Wang | Zendy; Na Wang | Zendy; Jinwen Wang | Zendy

Open Access

Efficacy and safety of Corbrin Capsule on malnutrition, inflammation, and atherosclerosis syndrome in patients with uremia: systematic review and meta-analysis

Author(s) -

Zhang-Ru Rui,

Yiru Wang,

Na Wang,

Jinwen Wang

Publication year - 2022

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-22-291

Subject(s) - medicine , uremia , meta analysis , cochrane library , blood urea nitrogen , inclusion and exclusion criteria , creatinine , malnutrition , renal function , confidence interval , capsule , gastroenterology , systematic review , medline , pathology , alternative medicine , botany , political science , law , biology

Uremia is a clinical syndrome caused by the development of chronic renal failure to the end-stage. Corbrin Capsule has the effect of tonifying the lungs and kidneys and improving the essence and qi, which can improve the metabolic disorders of the body. However, there is currently no systematic evaluation of the efficacy of Corbrin Capsule in the treatment of uremia malnutrition, inflammation, and atherosclerosis (MIA) syndrome. This paper aiming to provide a reference for improving the prognosis of uremic MIA patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research